A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
暂无分享,去创建一个
[1] F. Hofmann,et al. A Stimulatory Role for cGMP-Dependent Protein Kinase in Platelet Activation , 2003, Cell.
[2] R. Haslam,et al. Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen‐induced platelet aggregation by nitroprusside * , 2002, British journal of haematology.
[3] Xiaoping Du,et al. A Mitogen-activated Protein Kinase-dependent Signaling Pathway in the Activation of Platelet Integrin αIIbβ3 * , 2001, The Journal of Biological Chemistry.
[4] R. Bodnar,et al. Regulation of von Willebrand Factor Binding to the Platelet Glycoprotein Ib-IX by a Membrane Skeleton-dependent Inside-out Signal* , 2001, The Journal of Biological Chemistry.
[5] U. Walter,et al. Actin-based motility: stop and go with Ena/VASP proteins. , 2001, Trends in biochemical sciences.
[6] FranzHofmann,et al. Mechanisms of NO/cGMP-Dependent Vasorelaxation , 2000 .
[7] U. Walter,et al. KT5823 Inhibits cGMP-dependent Protein Kinase Activity in Vitro but Not in Intact Human Platelets and Rat Mesangial Cells* , 2000, Journal of Biological Chemistry.
[8] T. Lincoln,et al. Activation of Mitogen-activated Protein Kinase Pathways by Cyclic GMP and Cyclic GMP-dependent Protein Kinase in Contractile Vascular Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.
[9] R. Haslam,et al. Cyclic Nucleotides and Phosphodiesterases in Platelets , 1999, Thrombosis and Haemostasis.
[10] K. Knobeloch,et al. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] P. Klatt,et al. Increased Adhesion and Aggregation of Platelets Lacking Cyclic Guanosine 3′,5′-Monophosphate Kinase I , 1999, The Journal of experimental medicine.
[12] A. Aszódi,et al. The vasodilator‐stimulated phosphoprotein (VASP) is involved in cGMP‐ and cAMP‐mediated inhibition of agonist‐induced platelet aggregation, but is dispensable for smooth muscle function , 1999, The EMBO journal.
[13] H. Granger,et al. Protein Kinase G Mediates Vascular Endothelial Growth Factor-induced Raf-1 Activation and Proliferation in Human Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[14] U. Walter,et al. Analysis and Regulation of Vasodilator-stimulated Phosphoprotein Serine 239 Phosphorylation in Vitro and in Intact Cells Using a Phosphospecific Monoclonal Antibody* , 1998, The Journal of Biological Chemistry.
[15] T. Lincoln,et al. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Wehland,et al. Mena, a Relative of VASP and Drosophila Enabled, Is Implicated in the Control of Microfilament Dynamics , 1996, Cell.
[17] M. Trueba,et al. Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside. , 1996, Molecular pharmacology.
[18] U. Walter,et al. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. , 1994, European journal of biochemistry.
[19] M. Krieger,et al. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. , 1994, The Journal of biological chemistry.
[20] U. Walter,et al. Defective nitrovasodilator-stimulated protein phosphorylation and calcium regulation in cGMP-dependent protein kinase-deficient human platelets of chronic myelocytic leukemia. , 1993, The Journal of biological chemistry.
[21] J. Beavo,et al. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. , 1992, Biochemical pharmacology.
[22] Xiaoping Du,et al. Ligands “activate” integrin α IIb β 3 (platelet GPIIb-IIIa) , 1991, Cell.
[23] R. Haslam,et al. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. , 1990, Molecular pharmacology.
[24] M. Hagiwara,et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.
[25] U. Walter,et al. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. , 1990, The Journal of biological chemistry.
[26] U. Walter,et al. Purification of a vasodilator-regulated phosphoprotein from human platelets. , 1989, European journal of biochemistry.
[27] U. Walter,et al. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases. , 1987, European journal of biochemistry.
[28] R. Colman,et al. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. , 1984, Biochemistry.
[29] M. Haddox,et al. Cyclic GMP metabolism and involvement in biological regulation. , 1977, Annual review of biochemistry.
[30] E. Beachey,et al. Interaction of a chick skin collagen fragment (alpha1-CB5) with human platelets. Biochemical studies during the aggregation and release reaction. , 1975, The Journal of biological chemistry.
[31] R. Haslam,et al. Cytochalasin B, the blood platelet release reaction and cyclic GMP , 1975, Nature.